Cardiff Oncology, Inc.

NASDAQ:CRDF

Biotechnology

Healthcare
$0.84 +2.12%

+$0.03 today

Market cap
$65.27M
Beta
1.38
P/E (TTM)
-1.8
EPS (TTM)
-$0.65
52W Low $1.16High $4.56

Volume 0.86M

Average 1.05M

Balance Sheet

Inspect the capital base behind the business.

Assets

$61.88M

FY 2025 · Annual

-36.3% YoY

Liabilities

$16.50M

FY 2025 · Annual

+15.8% YoY

Equity

$45.39M

FY 2025 · Annual

-45.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents11.94M16.35M21.66M51.47M17.47M
Short-term Investments128.88M88.92M53.17M40.28M40.83M
Net Receivables535K771K288K773K182K
Inventory00000
Other Current Assets05.25M2.3M2.54M1.64M
Total Current Assets146.13M111.28M77.41M95.05M60.13M
Property, Plant & Equipment (Net)3.18M3.52M2.95M2.07M1.21M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets239K1.39M1.28M69K549K
Total Non-current Assets3.42M4.91M4.23M2.14M1.76M
Total Assets149.54M116.19M81.64M97.19M61.88M
Account Payables1.44M1.96M1.97M4.82M8.09M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.48M1.85M5.05M2.75M2.43M
Total Current Liabilities6.56M7.81M10.44M13.43M16.39M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities2.57M2.04M1.46M813K102K
Total Liabilities9.13M9.85M11.9M14.24M16.5M
Common Stock4K4K4K7K7K
Retained Earnings(259.81M)(298.1M)(339.54M)(384.18M)(430.03M)
Accumulated OCI(142K)(395K)(67K)34K50K
Other Stockholders Equity(139K)0000
Minority Interest00000
Total Equity140.42M106.34M69.74M82.95M45.39M
Total Debt3.12M2.72M2.15M1.52M832K
Net Debt(8.82M)(13.63M)(19.51M)(49.95M)(16.64M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$8.5M
Short-term Investments$37.5M
Receivables$191.0K
Other Current$1.1M
Total Current Assets$47.3M
PP&E (Net)$986.0K
Other Non-current$844.0K
Total Non-current Assets$1.8M
Total Assets$49.2M

Analysis

Selected assets total $49.2M for Latest. The largest visible component is Short-term Investments at $37.5M, about 76.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
3Initial statement of beneficial ownershipOct 27, 2026
8-KCurrent reportOct 27, 2026
8-KCurrent reportOct 22, 2026

How much cash does CRDF have?

Cardiff Oncology, Inc. (CRDF) reported $17.47M in cash and equivalents in fiscal 2025.

How much debt does CRDF carry?

Cardiff Oncology, Inc. (CRDF) reported $832,000.00 of total debt, with net debt of -$16.64M.